Saadia Andaleeb
National University of Sciences and Technology
6 Papers
3 Citations
Saadia Andaleeb is an academic researcher from National University of Sciences and Technology. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide
Molly O’Reilly,L C Sommerfeld,Christopher O’Shea,Sophie Broadway-Stringer,Saadia Andaleeb,J. Reyat,S N Kabir,D. Stastny,Antonia Malinova,D. Delbue,Lisa Fortmueller,Katja Gehmlich,Davor Pavlovic,B. Skryabin,A. Holmes,P. Kirchhof,Larissa Fabritz +16 more
TL;DR: In this article , the authors designed a new murine model carrying the Scn5a-M1875T mutation enabling them to study the effects of the Nav1.5 mutation in detail in vivo and in vitro using patch clamp and microelectrode recording of atrial cardiomyocytes, optical mapping, electrocardiogram, echocardiography, gravimetry, histology, and biochemistry.
•Journal Article
Determination of Antibiotic Resistance Prototype and in vitro R Plasmid Conjugation of Escherichia coli Isolates from Broiler Feces
Adnan Amin,Muhammad Ayaz Khan,Uzma Haroon,Sheikh Muhammad Farooq Azam,Saadia Andaleeb,Pir Bux Ghumro +5 more
TL;DR: The prevalence of antibiotic resistance in poultry farms was a prevalence seen a year ago, but now it is more likely to be a pre- prevalence.
1
Determination of antibiotic resistance pattern in Escherichia coli strains isolated from animal faeces in a farm house
TL;DR: The present study evaluated the antibiotic resistance pattern of Escherichia coli strains isolated from animals to ascertain the levels of antibiotic resistance pervasiveness and found about 50-75% of the strains were reported as resistant to more than five antibiotics (multidrug-resistant).
1
รูืิีะการถ่ิ R แบบคอนจูัื Escherichia coli ทีุ้่
Adnan Amin,Muhammad Ayaz Khan,Uzma Haroon,Sheikh Muhammad,Farooq Azam,Saadia Andaleeb,Shah Abdul +6 more
- 01 Jan 2012
TL;DR: In this paper, E coli (E. coli), streptomycin (88-92%), amoxicillin (68-76%), ceftrioxone (60-68%), cefepime (5668%), Meropenem (16-28%), ciprofloxacin (24-28), Ofloxaxacin(36-40%), Ofloxin (36,40%) and amoxiclav (40%)